AbbVie (ABBV) exec says that they have plenty of firepower to pursue both early and late stage M&A opportunities
Importance
Level 1
#ABBVIE INC#ABBV.US#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#US EQUITIES